Plus, a biotech with 'potentially game-changing' trial results, the 'too far, too fast' rally you might still be betting on, and more.
Oct 18, 2025
Aug 8, 2026
•
1 min read
Plus, a Street-high target on a lagging tech giant...
Aug 1, 2026
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
Plus, Wall Street's highest target on a major data platform...